Oncology Drug Development Information Resources

If you are involved in drug development in the oncology field and are being overwhelmed with a barrage of information and wish someone would put it all in order, update it on a regular basis, and make it available on the Internet in a simple to use format that is searchable by a variety of meaningful ways to meet any requirement, then try New Medicine’s Oncology KnowledgeBASE (nm/OK) where with the click of a mouse you may learn about the:

competitive environment by type of drug/mechanism (how many agents are in development based on the same or related mechanisms of action by current status, developer, collaborator and technology)

competitive environment by targeted indication (what other agents are in development for the targeted indication by status i.e., research/lead identification, preclinical or clinical trial by latest phase, including detailed descriptions of completed or ongoing clinical trials)

competitor(s) status and pipelines (which developers are involved in this area, the status of their agent(s), their collaborators, and pipelines)

technology opportunities/threats (are there unique developments in terms of administration route, delivery options ongoing that may impact the outlook of a specific product class)

market opportunities (what are the market opportunities within the specific indications based on cancer incidence and global markets of competitive/related agents)

clinical evaluation programs, trial protocols and results (detailed protocols and interim and final results of monotherapy and combination trials by agents involved; locate combination trials for the newly approved commercially available anticancer drugs that may result in product use extensions)

molecular targets (obtain development status of agents addressing over 1200 oncology-related molecular targets, and learn about the mechanisms and pathways involved that will determine future clinical programs)

Currently, among other information, nm/OK, residing at http://www.nmok.net, contains comprehensive records of about 3,500 novel or approved anticancer agents on a global basis and, in addition, about 1,000 records of drugs treating the complications of cancer and its treatment (pain, infection, anemia, neutropenia, etc.).

Did you know that currently, on a global basis, there are:

73 novel angiogenesis inhibitors in development

28 drugs in development addressing the EGF pathway (monoclonal antibodies, small molecule drugs, vaccines, etc.)

– 300 agents in development to potentially treat prostate cancer with 194 actually in clinical development

– 86 anticancer agents either evaluated or currently in clinical development in phase III clinical trials

– 17 new drugs being evaluated in combination with gemcitabine (Gemzar; Lilly)

– 39 new drugs/technologies in the Novartis pipeline in development in-house and through affiliations

– 20 different anticancer drugs in development originated at M. D. Anderson Cancer Center (academic origins are listed for over 300 drugs currently in development)

– 68 human monoclonal antibodies (MAb) in development against a variety of malignancies; over 250 MAb-based agents are under investigation at various stages of development

Numerous executives in large and small drug and biotechnology companies worldwide are currently using nm/OK on a daily basis. It is invaluable in identifying licensing/collaboration opportunities, in preparing complex decision-making reports, in making highly informed presentations, and in evaluating data by others in real time. For those in small-to-medium size companies, it represents a very cost-effective way to maintain heightened awareness regarding developments in this fast paced field; for those in large companies, it will free you from queuing to get your questions answered, and provide you with a means of placing all information instantaneously in prospective and remaining constantly informed.

If you would like to see first hand how this resource can exponentially increase your productivity in evaluating the oncology sector, call us at 949 830-0448, and we will walk you through nm/OK, and give you a temporary pass to try the database for a week, at your leisure, at no obligation.

New Medicine
http://www.nmok.net

About the Author

admin has written 6390 stories on this site.

Write a Comment

Gravatars are small images that can show your personality. You can get your gravatar for free today!

You must be logged in to post a comment.

Copyright © 2009 Medical News. All rights reserved.
Powered by WordPress.org, Custom Theme and ComFi.com Calling Card Company.
Close